| [10] | Severe dysbiosis and specific Haemophilus and Neisseria signatures as hallmarks of the oropharyngeal microbiome in critically ill COVID-19 patients (de Castilhos, Juliana, Zamir, Eli, Hippchen, Theresa, Rohrbach, Roman, Schmidt, Sabine, Hengler, Silvana, Schumacher, Hanna, Neubauer, Melanie, Kunz, Sabrina, Müller-Esch, Tonia, Hiergeist, Andreas, Gessner, André, Khalid, Dina, Gaiser, Rogier, Cullin, Nyssa, Papagiannarou, Stamatia M, Beuthien-Baumann, Bettina, Krämer, Alwin, Bartenschlager, Ralf, Jäger, Dirk, Müller, Michael, Herth, Felix, Duerschmied, Daniel, Schneider, Jochen, Schmid, Roland M, Eberhardt, Johann F, Khodamoradi, Yascha, Vehreschild, Maria J. G. T., Teufel, Andreas, Ebert, Matthias P, Hau, Peter, Salzberger, Bernd, Schnitzler, Paul, Poeck, Hendrik, Elinav, Eran, Merle, Uta and Stein-Thoeringer, Christoph K), In Clin. Infect. Dis.. |
| [9] | Lactose drives \emphEnterococcus expansion to promote graft-versus-host disease (Stein-Thoeringer, C. K., Nichols, K. B., Lazrak, A., Docampo, M. D., Slingerland, A. E., Slingerland, J. B., Clurman, A. G., Armijo, G., Gomes, A. L. C., Shono, Y., Staffas, A., Burgos da Silva, M., Devlin, S. M., Markey, K. A., Bajic, D., Pinedo, R., Tsakmaklis, A., Littmann, E. R., Pastore, A., Taur, Y., Monette, S., Arcila, M. E., Pickard, A. J., Maloy, M., Wright, R. J., Amoretti, L. A., Fontana, E., Pham, D., Jamal, M. A., Weber, D., Sung, A. D., Hashimoto, D., Scheid, C., Xavier, J. B., Messina, J. A., Romero, K., Lew, M., Bush, A., Bohannon, L., Hayasaka, K., Hasegawa, Y., Vehreschild, M. J. G. T., Cross, J. R., Ponce, D. M., Perales, M. A., Giralt, S. A., Jenq, R. R., Teshima, T., Holler, E., Chao, N. J., Pamer, E. G., Peled, J. U. and van den Brink, M. R. M.), In Science, volume 366. |
| [8] | Microbiota-based markers predictive of development of Clostridioides difficile infection (Berkell, M., Mysara, M., Xavier, B.B., Werkhoven, C.H., Monsieurs, P., Lammens, C., Ducher, A., Vehreschild, M.J.G.T., Goossens, H., Gunzburg, J., Bonten, M.J.M. and Malhotra-Kumar, S.), In Nat. Commun., volume 12. |
| [7] | Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infections (Bestfater, Christian, Vehreschild, Maria J.G.T., Stallmach, Andreas, Tüffers, Kester, Erhardt, Andreas, Frank, Thorsten, Glück, Thomas, Goeser, Felix, Sellge, Gernot, Solbach, Philipp, Eisenlohr, Herbert and Storr, Martin), In Dig. Dis. Sci., volume 53. |
| [6] | Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January−December 2016 (Biehl, Lena M., Higgins, Paul G., Stemler, Jannik, Gilles, Meyke, Peter, Silke, Dörfel, Daniela, Vogel, Wichard, Kern, Winfried V., Gölz, Hanna, Bertz, Hartmut, Rohde, Holger, Klupp, Eva-Maria, Schafhausen, Philippe, Salmanton-García, Jon, Stecher, Melanie, Wille, Julia, Liss, Blasius, Xanthopoulou, Kyriaki, Zweigner, Janine, Seifert, Harald and Vehreschild, Maria J.G.T.), In Eurosurveillance, volume 27. |
| [5] | Potential biomarkers to predict outcome of faecal microbiota transfer for recurrent Clostridioides difficile infection (Farowski, Fedja, Solbach, Philipp, Tsakmaklis, Anastasia, Brodesser, Susanne, Cruz Aguilar, M. Rebeca, Cornely, Oliver A., Dettmer, Katja, Higgins, Paul G., Suerbaum, Sebastian, Jazmati, Nathalie, Oefner, Peter J. and Vehreschild, Maria J.G.T.), In Dig. Dis. Sci., volume 51. |
| [4] | A standardised model for stool banking for faecal microbiota transplantation: A consensus report from a multidisciplinary UEG working group (Keller, Josbert J., Ooijevaar, Rogier E., Hvas, Christian L., Terveer, Elisabeth M., Lieberknecht, Simone C., Högenauer, Christoph, Arkkila, Perttu, Sokol, Harry, Gridnyev, Oleksiy, Mégraud, Francis, Kump, Patrizia K., Nakov, Radislav, Goldenberg, Simon D., Satokari, Reetta, Tkatch, Sergiy, Sanguinetti, Maurizio, Cammarota, Giovanni, Dorofeev, Andrey, Gubska, Olena, Laniro, Gianluca, Mattila, Eero, Arasaradnam, Ramesh P., Sarin, Shiv K., Sood, Ajit, Putignani, Lorenza, Alric, Laurent, Baunwall, Simon M. D., Kupcinskas, Juozas, Link, Alexander, Goorhuis, Abraham G., Verspaget, Hein W., Ponsioen, Cyriel, Hold, Georgina L., Tilg, Herbert, Kassam, Zain, Kuijper, Ed J., Gasbarrini, Antonio, Mulder, Chris J. J., Williams, Horace R. T. and Vehreschild, Maria J. G. T.), In United European Gastroenterol. J., volume 9. |
| [3] | An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones (Vehreschild, Maria J. G. T., Ducher, Annie, Louie, Thomas, Cornely, Oliver A., Feger, Celine, Dane, Aaron, Varastet, Marina, Vitry, Fabien, de Gunzburg, Jean, Andremont, Antoine, Mentré, France and Wilcox, Mark H.), In J. Antimicrob. Chemoth., volume 77. |
| [2] | Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics (Werkhoven, C.H., Ducher, A., Berkell, M., Mysara, M., Lammens, C., Torre-Cisneros, J., Rodríguez-Baño, J., Herghea, D., Cornely, O.A., Biehl, L.M., Bernard, L., Dominguez-Luzon, M.A., Maraki, S., Barraud, O., Nica, M., Jazmati, N., Sablier-Gallis, F., Gunzburg, J., Mentré, F., Malhotra-Kumar, S., Bonten, M.J.M. and Vehreschild, M. J. G. T.), In Nat. Commun., volume 12. |
| [1] | Distinct impact of antibiotics on the gut microbiome and resistome: A longitudinal multicenter cohort study (Willmann, Matthias, Vehreschild, Maria J. G. T., Biehl, Lena M., Vogel, Wichard, Dörfel, Daniela, Hamprecht, Axel, Seifert, Harald, Autenrieth, Ingo B. and Peter, Silke), In BMC Biol., volume 17. |